No Detail Found!

Effectiveness of metformin in recurrent miscarriages in a woman with polycystic ovarian syndrome

Author(s)
Huma Afridi Departments of Gynecology and Obstetrics, Sialkot Medical College, Pakistan
Binish Tahir Departments of Gynecology and Obstetrics, WMO, Pakistan
Beenish Riaz Islamic International medical college, Islamabad, Pakistan
Fareesa Waqar Nawaz Sharif Medical College, Gujrat, Pakistan
Itaat Ullah Khan Afridi Nawaz Sharif Medical College, Gujrat, Pakistan
Iqra Waheed Biostatistician, Pakistan
Abstract
Objective: To evaluate the efficacy of metformin in treatment of recurrent miscarriage in women with polycystic ovary syndrome versus a placebo. Methodology: This randomized controlled trial was carried out at Department of Gynecology and Obstetrics, Imran Idrees Teaching Hospital, Sialkot Medical College, Sialkot from 1st January to 30th June 2023. Women were divided in two groups. One group continued oral metformin 1000-2000 mg daily up to 24th weeks with folic acid 5mg daily in first trimester act as cases and other group stopped metformin after the confirmation of pregnancy acted as control. Patients were followed to detect any pregnancy loss in two groups. Data were analyzed in SPSS 25. Results: In metformin group, there were 26 (86.7%) cases and in control group there were 13 (43.3%) cases. Mean age of cases in metformin group was 27.33±5.09 years and in control group 30.87±6.36 years. Mean gestational age in metformin group was 26.77±3.42 weeks and in control group it was 26.77±3.42. Effectiveness was observed in 4 (13.3%) cases in metformin group and 17 (56.7%) cases in control group the treatment was not effective. Effectiveness was significantly high in metformin group as compared to control group (p<0.05). Conclusion: For non-obese women with PCOS, metformin is an ovulation induction drug having benefits over clomiphene and other standard therapies for anovulatory infertility.
Publication Details
Page(s) 575-578
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 49, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
Infertility, metformin, insulin resistance, Hirsutism, Polycystic ovary syndrome., anovulation, hyperandro-genism
References
Kumar P,Khan K. .2012 .Effects of metformin use in pregnant patients with polycystic ovary syndrome. J Hum Reprod Sci, 5 : 166-9.
Ghazeeri GS,Nassar AH,Younes Z,Awwad JT .2012 .Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview. Acta Obstetr Gynecol Scand, 91 : 658-78.
Ispasoiu C-A,Chicea R,Stamatian FV,Ispasoiu F .2013 .High fasting insulin levels and insulin resistance may be linked to idiopathic recurrent pregnancy loss: a case-control study. Int J Endocrinol, : 1-5.
Nawaz FH,Rizvi J .2010 .Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome. Gynecol Obstetr Invest, 69 : 184-9.
Rojas J,Chávez-Castillo M,Bermúdez V .2014 .The role of metformin in metabolic disturbances during pregnancy: polycystic ovary syndrome and gestational diabetes mellitus. Int J Reprod Med, : 1-15.
Swadi AA,Swadi SM,Al-Qadisiyah Med SM . .Effect of metformin on pregnancy outcomes in women with PCOS. , 10 : 187-95.
Lautatzis M-E,Goulis DG,Vrontakis M. Efficacy .2013 .and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review. Metabolism, 62 : 1522-34.
Cocksedge KA,Li T-C,Saravelos SH,Metwally M. .2008 .A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage. Reprod Biomed Online, 17 : 151-60.
Yang CJ,Stone P,Stewart AW .2006 .The epidemiology of recurrent miscarriage: a descriptive study of 1214 prepregnant women with recurrent miscarriage. Aust NZ J Obstet Gynaecol, 46 : 316-22.
Haq F,Rizvi J .2008 .Infertility and polycystic ovarian syndrome: A study of association between body mass index and intrafamily marriages. Gynaecol Obstet Invest, 65 : 269-74.
Balen AH,Dresner M,Scott EM,Drife JO .2006 .Should obese women with polycystic ovary syndrome receive treatment for infertility?. , : .
Ehrmann DA .2005 .Polycystic ovary syndrome. N Engl J Med, 352 : 1223-36.
Checa M,Requena A,Salvador C,Tur R,Callejo J,Espinos J .2005 .Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome. Hum Reprod Update, 11 : 375-90.
Haq F,Aftab O,Rizvi J. .2007 .Clinical, biochemical and ultrasonographic features of infertile women with polycystic ovarian syndrome. J Coll Physicians Surg Pak, 17 : 76-80.
Boomsma C,Eijkemans M,Hughes E,Visser G,Fauser B,Macklon N. .2006 .A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update, 12 : 673-83.
Moghetti P,Castello R,Negri C,Tosi F,Perrone F,Caputo M .2000 .Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebocontrolled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab, 85 : 139-46.
Al-Biate MA .2015 .Effect of metformin on early pregnancy loss in women with polycystic ovary syndrome. Taiwan J Obstet Gynecol, 54 : 266-9.
Khattab S,Mohsen IA,Foutouh IA,Ramadan A,Moaz M,Al-Inany H M .2006 .Metformin reduces abortion in pregnant women with polycystic ovary syndrome. Gynecol Endocrinol, 22 : 680-4.
0

Citations

0

Downloads

75

Views